Volume : 08, Issue : 09, September – 2021
Title:
60.CBC PROFILE AND BIOCHEMICAL ANALYSIS OF COVID-19 PATIENTS
Authors :
Dr Haroon Nawaz, Dr Ayesha Akram Choudhry, Dr Shaikh Muhammad Abdullah Azeem, Dr Tamaniat Manzoor, Dr Ranjeeta Rajni, Dr Faizan Rasheed, Dr Arslan Tariq, Dr Mahpara Munir, Dr Saba Hammad
Abstract :
Introduction: COVID-19 is basically a RNA virus and the nucleic acid is about 30 kb long, positive in sense, single stranded and polyadenylated. Objectives: The main objective of the study is to analyse the CBC value and biochemical analysis of COVID-19 patients. Material and methods: This cross sectional study was conducted in Punjab Health Department during January 2021 to June 2021. Outpatients with suspected COVID-19 having initial respiratory signs (including sore throat without shortness of breath), fever, cough, muscle ache, and headache were included. Pharyngeal swab samples were collected for COVID-19 test on presentation. Results: Patients with positive RT-PCR had significantly higher NEU count (p = 0.0001), and CRP (p = 0.04), LDH (p = 0.0001), AST (p = 0.001), ALT (p = 0.0001), and Urea (p = 0.001) levels in serum. In addition, patients with positive RT-PCR had lower WBC count (p = 0.0001) and serum albumin level (p = 0.0001) compared to others. Two hundred cases with the mean age of 41.3± 14.6 (range: 19-78) years were studied (0.53% male). Conclusion: It is concluded that based on the findings of this study ALT, CRP, NEU, LDH, and Urea have very good accuracy in predicting cases with positive RT-PCR for COVID-19, respectively.
Cite This Article:
Please cite this article in press Haroon Nawaz et al, CBC Profile and Biochemical Analysis of Covid-19 Patients., Indo Am. J. P. Sci, 2021; 08(9).
Number of Downloads : 10
References:
REFERENCES:
1. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020
2. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020:200642.
3. Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID‐19. Journal of Medical Virology. 2020
4. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID‐19 infection. American Journal of Hematology
5. Al Ghamdi M, Alghamdi KM, Ghandoora Y, Alzahrani A, Salah F, Alsulami A, et al. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC infectious diseases. 2016;16(1):174.
6. Wang J-T, Sheng W-H, Fang C-T, Chen Y-C, Wang J-L, Yu C-J, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerging infectious diseases. 2004;10(5):818.
7. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2020:101623.
8. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. :2020.
9. Kui L, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese medical journal. :2020.
10. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–13.